David Hung

Companies

• Nuvation Bio Inc.Board member Feb 12, 2021 to now¹
• Nuvation Bio Inc.Chief executive officer Feb 12, 2021 to now¹
• Nuvation Bio Inc.President Feb 12, 2021 to now¹
• NovoCure LtdBoard member Jun 4, 2018 to now²
• ESTABLISHMENT LABS HOLDINGS INC.Board member Jul 18, 2018 to May 27, 2020³
• Sio Gene Therapies Inc.Board member Apr 11, 2017 to Jan 3, 2018⁴
• Sio Gene Therapies Inc.Principal Executive Officer Apr 11, 2017 to Jan 3, 2018⁴
• MedivationBoard member Jan 30, 2006 to Sep 30, 2016⁵
• MedivationChief executive officer Jan 30, 2006 to Sep 30, 2016⁵
• MedivationPresident Jan 30, 2006 to Sep 30, 2016⁵
• Opexa TherapeuticsBoard member May 25, 2006 to Apr 7, 2011⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NBNuvation Bio Inc. NUVB59,281,054 shares⁷$263.5M at $4.45Jun 16, 2025
• NNovoCure Ltd NVCR32,075 shares⁸$477.3K at $14.88Jun 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 3, 2026Granted 11,610 shares of NovoCure Ltd⁸
• Jun 2, 2026Sold 2,945 shares at $15.77 of NovoCure Ltd⁹
• Jun 16, 2025Bought 500,000 shares at $1.79 of Nuvation Bio Inc.⁷
• Jun 4, 2025Granted 11,215 shares of NovoCure Ltd¹⁰
• Jun 3, 2025Sold 999 shares at $17.30 of NovoCure Ltd¹¹
• Apr 7, 2025Bought 300,000 shares at $1.63 of Nuvation Bio Inc.¹²
• Apr 4, 2025Bought 200,000 shares at $1.66 of Nuvation Bio Inc.¹²
• Jun 5, 2024Granted 4,053 shares of NovoCure Ltd¹³
• Jun 8, 2022Granted 2,427 shares of NovoCure Ltd¹⁴
• Mar 2, 2021Other 368,408 shares of Nuvation Bio Inc.¹⁵